Skip Navigation

European Journal of Heart Failure 2003 5(2):201-209; doi:10.1016/S1388-9842(02)00201-5
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wright, S.P.
Right arrow Articles by Doughty, R.N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wright, S.P.
Right arrow Articles by Doughty, R.N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2002 European Society of Cardiology

Factors influencing the length of hospital stay of patients with heart failure

S.P. Wrighta,*, D. Verouhisb, G. Gamblea, K. Swedbergb, N. Sharpea and R.N. Doughtya

a Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland Private Bag 92019, Auckland, New Zealand
b Department of Medicine, Sahlgrenska University Hospital/Östra, Göteborg University Goteborg, Sweden

* Corresponding author. Tel.: +64-9-307-4949x7654; fax: +64-9-302-2101 E-mail address: sp.wright{at}auckland.ac.nz


   Abstract

Introduction: Heart failure (HF) is characterised by frequent hospital admissions and prolonged length of hospital stay. Admissions for HF have increased over the last decade while length of stay has decreased; the reasons for this change in length of stay are uncertain. This study investigates the effect of patient-related variables, in-hospital progress and complications on length of stay.

Methods: Patients admitted to Auckland Hospital general medical service and randomised into the Auckland Heart Failure Management Programme were included in this study.

Results: One hundred and ninety-seven patients were included in this study. Mean age 73 years, mean left ventricular ejection fraction 32%; 52% had one or more previous HF admissions and 75% were New York Heart Association class IV at admission. Median length of hospital stay was 6 days (IQR 4, 9) which is comparable to the national average from New Zealand admission databases. Longer than average length of stay, defined as >6 days, was associated with the presence of peripheral congestion, duration of treatment with intravenous diuretic, the development of renal impairment, other acute medical problems at admission, iatrogenic complications during hospital stay, and social problems requiring intervention. Factors independently associated with length of stay in the top quartile (>10 days) on logistic regression included the presence of oedema at admission (OR 10.5), change in weight during stay (OR 1.3), duration of treatment with iv diuretic (OR 7.5), the development of renal impairment (OR 9.8), concurrent respiratory problems requiring specific treatment (OR 3.8), and social problems requiring intervention (OR 6.8).

Conclusions: Peripheral congestion, concomitant acute medical problems requiring specific treatment, the development of renal impairment and the presence of social problems were related to a longer than average length of hospital stay. Multivariate models only partly explained variance in hospital stay, suggesting the importance of pre-admission and post-discharge factors, including the healthcare environment, the availability of primary and secondary care resources, and the threshold for hospital admission.

Key Words: Heart failure • Length of stay • Healthcare use • Hospitalisation • Inpatient management

Received November 6, 2001; Revised July 9, 2002; Accepted October 4, 2002


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur J Heart FailHome page
N. M. Hawkins, Z. Huang, K. S. Pieper, S. D. Solomon, L. Kober, E. J. Velazquez, K. Swedberg, M. A. Pfeffer, J. J.V. McMurray, A. P. Maggioni, et al.
Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT)
Eur J Heart Fail, March 1, 2009; 11(3): 292 - 298.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
N. M. Hawkins, M. C. Petrie, P. S. Jhund, G. W. Chalmers, F. G. Dunn, and J. J.V. McMurray
Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology
Eur J Heart Fail, February 1, 2009; 11(2): 130 - 139.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. D. Solomon, J. Dobson, S. Pocock, H. Skali, J. J.V. McMurray, C. B. Granger, S. Yusuf, K. Swedberg, J. B. Young, E. L. Michelson, et al.
Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure
Circulation, September 25, 2007; 116(13): 1482 - 1487.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. Gonseth, P. Guallar-Castillon, J. R. Banegas, and F. Rodriguez-Artalejo
The effectiveness of disease management programmes in reducing hospital re-admission in older patients with heart failure: a systematic review and meta-analysis of published reports
Eur. Heart J., September 2, 2004; 25(18): 1570 - 1595.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.